Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Feeder-free system for maintaining pluripotency in embryonic stem cells pioneered

08.01.2004


A newly discovered molecule, nicknamed "BIO", safely maintains human embryonic stem cells in a pluripotent state. Its chemical structure is pictured above. The molecule was originally identified and purified from the purple dye extracted from the mollusk Hexaplex trunculus


Molecule developed from marine mollusk overcomes risks of current methods

Human embryonic stem cell (HESC) lines, or cultures, in the U.S. are not suitable for use in the budding field of regenerative medicine. Their creation using mouse feeder cells, a specialized growth medium, allows scientists to study their basic characteristics, but ultimately the HESCs are too risky to develop in applied medicine because mouse-associated viruses possibly contaminate them.

Now, Rockefeller University researchers in collaboration with two European scientists, have discovered a way around this problem: they’ve devised a system for maintaining existing or new human stem cell lines that excludes the need for troublesome mouse feeder cells.



The findings also have an intriguing underpinning. A marine animal belonging to the gastropod mollusk group is the original source of the compound now in use in the new feeder-free system. The natural molecule from which the new compound has now been synthesized has been harvested for over 2500 years from the creature, known as the red mollusk, as a coveted purple dye.

The identification of the small molecule, pharmacological inhibitor system in stem cells, led by Ali Brivanlou, Ph.D., head of the laboratory of molecular vertebrate embryology and his research associate, Noburo Sato, Ph.D., so far demonstrates superior stability over other methods designed to circumvent the need for mouse feeder cells. Nature Medicine features Brivanlou, Sato and their colleagues’ results in its January 2004 edition. And though still early in the team’s experiments, the stem cells appear to progress and differentiate normally after the compound is removed.

This new system for maintaining pluripotency could be a providential break for basic researchers and clinicians investigating the potential of HESCs, as it is a potential first step in providing an unlimited source of tissue transplant if HESCs’ potential comes to fruition in clinical medicine.

It works like this: a newly purified compound from the purple dye of marine red mollusks - called 6-bromoindirubin-3’-oxime, or by its working acronym, "BIO"- has been shown by Rockefeller scientists to indirectly activate a crucial gene expression mechanism, called the Wnt signaling pathway, in embryonic cells. Wnt signaling occurs when the new compound inhibits a specific protein kinase in embryonic cells, called GSK-3. This enzyme plays an essential role in many normal and disease states from development to neurodegenerative disorders. It is involved in numerous pathways including a highly conserved and important one called the Wnt signaling pathway. When GSK-3 is inactivated, Wnt is active. Chemical inhibition of GSK-3 thus mimics activation of Wnt and this keeps HESCs in an active, undifferentiated state - one of the crucial basic qualities of embryonic stem cells.

"We know precisely how this compound works - that is, on which enzymes and pathways - and that it is very controllable," says Brivanlou. "This knowledge makes the compound useful not only in stem cell research but also, as we are already seeing in the lab, numerous other research areas."

The challenges of HESC applied research are well known, along with the possible rewards. Cultured stem cells must be capable of self-renewal in an undifferentiated state in order to be truly useful.

Brivanlou, a comparative embryologist who studies the basic molecular aspects of very early vertebrate embryonic development, studies embryonic stem cells to determine whether they truly possess the unique qualities with which they are credited. He along with his scientific colleagues already developed a set of research standards for determining what qualifies as an embryonic stem cell, and what remains to be confirmed about them before clinical researchers safely can consider using them in human research. The standards were published in Science in May 2003.

He also revealed, in 2003, a set of genetic markers for human embryonic stem cells, showing that they do not share a majority of their gene expression patterns with mouse embryonic stem cells, and that there is a highly specific genetic definition of embryonic cells that makes them stem cells - in other words, those cells that can give rise to all body cell types. This research was published in Developmental Biology in July 2003.

These accomplishments were deliberate and systematic. The new system hailed from an unanticipated source. Early in 2003, Laurent Meijer, a biochemist from the Roscoff Marine Biology Institute in France, while on sabbatical at Rockefeller University, studying protein kinases involved in neurodegenerative diseases in Dr. Paul Greengard’s laboratory, asked Brivanlou to test a new compound he and his Greek colleague, Leandros Skaltsounis, had derived from naturally- occurring indirubin of Mediterranean mollusks. The two scientists wanted to know if this new compound could act as a potent and selective pharmacological inhibitor of GSK-3, and therefore as potentially useful against neurodegenerative disorders.

"Protein kinases are very promising targets for the discovery of new therapeutic agents," says Meijer. "In particular, pharmacological inhibitors of GSK-3 have great potential for application to treat Alzheimer’s disease and other neurodegenerative disorders, as well as sleep disorders and depression." (There are 520 protein kinases encoded in the human genome.)

Brivanlou and his colleague Alin Vonica, M.D., Ph.D. confirmed that the synthetic compound was able to mimic Wnt activation in the classical model of frog early embryonic development. In the process, Brivanlou also discovered that the compound safely could arrest differentiation of stem cells in frog embryos, while allowing them to continue to self-renew.

Thus far, Brivanlou has applied the BIO compound to frog, mouse and human stem cells, with favorable results.

Lynn Love | Rockefeller University
Further information:
http://www.rockefeller.edu/pubinfo/010504b.php

More articles from Life Sciences:

nachricht Seeing on the Quick: New Insights into Active Vision in the Brain
15.08.2018 | Eberhard Karls Universität Tübingen

nachricht New Approach to Treating Chronic Itch
15.08.2018 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

Interactive software tool makes complex mold design simple

16.08.2018 | Information Technology

Study tracks inner workings of the brain with new biosensor

16.08.2018 | Health and Medicine

Fraunhofer HHI develops next-generation quantum communications technology in the UNIQORN project

16.08.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>